Abbott Laboratories (ABT)

$89.27 +0.94 (1.06%)
Market Cap 154.95B
Revenue (ttm) 44.33B
Net Income (ttm) 6.52B
EPS (ttm) N/A
PE Ratio 17.68
Forward PE 16.82
Profit Margin 14.72%
Debt to Equity Ratio 0.65
Volume 16,415,300
Avg Vol 13,008,872
Day's Range N/A - N/A
Shares Out 1.74B
Stochastic %K 16%
Beta 0.61
Analysts Strong Sell
Price Target $116.81

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement ther...

Industry: Medical Devices
Sector: Healthcare
Phone: 224 667 6100
Address:
100 Abbott Park Road, Abbott Park, United States
therofl
therofl Jul. 15 at 11:24 PM
$ABT suck mike hawk
0 · Reply
therofl
therofl Jul. 15 at 11:12 PM
$ABT shitty shit shit
0 · Reply
yourfinancialteacher
yourfinancialteacher Jul. 15 at 11:10 PM
$ABT 👀
0 · Reply
spearnreel
spearnreel Jul. 15 at 8:20 PM
$BSX Someone liking $ABT earnings due out tomorrow.
1 · Reply
DBRGLong
DBRGLong Jul. 15 at 8:06 PM
$ABT strong buying volume & spike right before the close for us. Someone wanted in prior to earnings tomorrow morning 🥂
0 · Reply
knowinvest
knowinvest Jul. 15 at 6:39 PM
$ABT I think earning will be ok, but the legal issue linked the nutrition business needs to be addressed by the management in order for the SP to move higher
0 · Reply
Oldpuck
Oldpuck Jul. 15 at 5:55 PM
$ABT Very weak heading into earnings
0 · Reply
1212JM
1212JM Jul. 15 at 5:41 PM
$ABT software all collapsing along side healthcare and people dumping money into hardware… they are literally chasing the next bubble. Such great time to buy some great companies at good valuations and prices while avoiding overbought bubbly stuff in $SPY
0 · Reply
DragonOfBosnia
DragonOfBosnia Jul. 15 at 4:47 PM
$ABT $BSX $MDT 25-45% up from here.. by end of year
0 · Reply
eWhispers
eWhispers Jul. 15 at 2:38 PM
#earnings after the close on Wednesday, July 15, 2026, and before the open on Thursday, July 16, 2026 https://www.earningswhispers.com/calendar $TSM $UNH $UAL $GE $ABT
0 · Reply
Latest News on ABT
2 ‘Strong Buy’ Dividend Aristocrat Stocks to Grab Right Now for August Payouts

2026-07-10T23:36:54.000Z - 5 days ago

2 ‘Strong Buy’ Dividend Aristocrat Stocks to Grab Right Now for August Payouts

ABBV

Abbott price target lowered to $112 from $120 at Evercore ISI

2026-07-06T12:40:26.000Z - 9 days ago

Abbott price target lowered to $112 from $120 at Evercore ISI

Tandem Diabetes launches t:slim X2 compatibility with Abbott’s FreeStyle

2026-07-01T12:41:00.000Z - 14 days ago

Tandem Diabetes launches t:slim X2 compatibility with Abbott’s FreeStyle

TNDM

Abbott initiated with an Outperform at Baird

2026-07-01T09:20:19.000Z - 14 days ago

Abbott initiated with an Outperform at Baird

3 Dividend Aristocrat Stocks Wall Street Loves Right Now — June 30, 2026

2026-06-30T20:47:27.000Z - 15 days ago

3 Dividend Aristocrat Stocks Wall Street Loves Right Now — June 30, 2026

KO NUE

Abbott initiated with an Outperform at Baird

2026-06-30T20:20:43.000Z - 15 days ago

Abbott initiated with an Outperform at Baird

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

Jun 29, 2026, 4:43 PM EDT - 16 days ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ADM APD BAC CMCSA CVS DIS FITB

Prosecutors prepped to charge Abbott, officials opted for settlement, WSJ says

2026-06-29T10:10:23.000Z - 16 days ago

Prosecutors prepped to charge Abbott, officials opted for settlement, WSJ says

US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports

Jun 28, 2026, 9:17 PM EDT - 17 days ago

US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports

The Baby Formula Probe Produced a Pile of Evidence. Then the DOJ Dropped the Case.

Jun 28, 2026, 9:00 PM EDT - 17 days ago

The Baby Formula Probe Produced a Pile of Evidence. Then the DOJ Dropped the Case.

3 Dividend Aristocrat Stocks with 20%+ Upside — June 25, 2026

2026-06-25T17:44:45.000Z - 20 days ago

3 Dividend Aristocrat Stocks with 20%+ Upside — June 25, 2026

CTAS MCD

Abbott hosts conference call for second-quarter earnings

Jun 25, 2026, 9:00 AM EDT - 20 days ago

Abbott hosts conference call for second-quarter earnings

Abbott and ALZpath announce license agreement

2026-06-24T12:35:52.000Z - 21 days ago

Abbott and ALZpath announce license agreement

ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing

Jun 24, 2026, 8:30 AM EDT - 21 days ago

ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing

ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test

Jun 24, 2026, 7:36 AM EDT - 21 days ago

ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test

3 Dividend Aristocrat Stocks Wall Street Loves Right Now — June 23, 2026

2026-06-23T22:53:44.000Z - 22 days ago

3 Dividend Aristocrat Stocks Wall Street Loves Right Now — June 23, 2026

NEE WMT

Missouri appeals court won't send Abbott's appeal of $495 million preterm baby formula verdict to higher court

Jun 23, 2026, 1:34 PM EDT - 22 days ago

Missouri appeals court won't send Abbott's appeal of $495 million preterm baby formula verdict to higher court

New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents

Jun 22, 2026, 12:00 PM EDT - 23 days ago

New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents

Living Longer Is Big Business. These Stocks Will Benefit.

Jun 18, 2026, 2:14 PM EDT - 27 days ago

Living Longer Is Big Business. These Stocks Will Benefit.

DXCM GH HIMS PLNT

The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 4 weeks ago

The Healthcare M&A Wave

ALNY AMGN AMRX ANTX AZN BDX BEAM

Citi sum-of-the-parts analysis shows Abbott share upside

2026-06-17T10:57:22.000Z - 4 weeks ago

Citi sum-of-the-parts analysis shows Abbott share upside

Abbott declares 410th consecutive quarterly dividend

Jun 12, 2026, 2:29 PM EDT - 4 weeks ago

Abbott declares 410th consecutive quarterly dividend

Abbott price target lowered to $102 from $120 at BofA

2026-06-12T10:41:20.000Z - 4 weeks ago

Abbott price target lowered to $102 from $120 at BofA

New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

Jun 8, 2026, 9:00 AM EDT - 5 weeks ago

New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

The U.S. stock market is facing historic downside risk — these 10 low-volatility stocks can protect your portfolio

Jun 6, 2026, 10:01 AM EDT - 5 weeks ago

The U.S. stock market is facing historic downside risk — these 10 low-volatility stocks can protect your portfolio

GIS KMB MDT O PPL ROP SNA

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

Jun 6, 2026, 9:00 AM EDT - 5 weeks ago

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

Abbott Labs must face lawsuit over PediaSure children's growth claims

Jun 4, 2026, 3:46 PM EDT - 5 weeks ago

Abbott Labs must face lawsuit over PediaSure children's growth claims

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

May 27, 2026, 9:00 AM EDT - 7 weeks ago

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening

May 27, 2026, 7:01 AM EDT - 7 weeks ago

ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening

Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026

May 26, 2026, 9:00 AM EDT - 7 weeks ago

Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026

Even a High-Priced Market Has Bargains. 10 Undervalued Blue-Chip Stocks.

May 15, 2026, 1:00 AM EDT - 2 months ago

Even a High-Priced Market Has Bargains. 10 Undervalued Blue-Chip Stocks.

ACN DHR HD MCD MDT MKC RSG

Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform

Apr 28, 2026, 9:00 AM EDT - 2 months ago

Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform

Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026

Apr 25, 2026, 12:30 PM EDT - 2 months ago

Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026

New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

Apr 17, 2026, 3:30 PM EDT - 3 months ago

New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt Sales

Apr 16, 2026, 11:22 AM EDT - 3 months ago

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt Sales

Abbott Laboratories Earnings Call Transcript: Q1 2026

Apr 16, 2026, 9:00 AM EDT - 3 months ago

Abbott Laboratories Earnings Call Transcript: Q1 2026

Abbott Laboratories Earnings release: Q1 2026

Apr 16, 2026, 9:00 AM EDT - 3 months ago

Abbott Laboratories Earnings release: Q1 2026

Abbott Laboratories Slides: Q1 2026

Apr 16, 2026, 9:00 AM EDT - 3 months ago

Abbott Laboratories Slides: Q1 2026

Abbott Laboratories Quarterly report: Q1 2026

Apr 16, 2026, 9:00 AM EDT - 3 months ago

Abbott Laboratories Quarterly report: Q1 2026

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Are Biting.

Apr 16, 2026, 8:05 AM EDT - 3 months ago

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Are Biting.

Abbott first-quarter results beat on cancer diagnostics, medical device strength

Apr 16, 2026, 7:33 AM EDT - 3 months ago

Abbott first-quarter results beat on cancer diagnostics, medical device strength

Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences

Apr 16, 2026, 7:30 AM EDT - 3 months ago

Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences

Jury orders Abbott to pay $53 million in preterm infant formula trial, media report says

Apr 9, 2026, 10:16 PM EDT - 3 months ago

Jury orders Abbott to pay $53 million in preterm infant formula trial, media report says

New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health

Apr 9, 2026, 9:00 AM EDT - 3 months ago

New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health

Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform

Mar 30, 2026, 9:00 AM EDT - 3 months ago

Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform

Abbott hosts conference call for first-quarter earnings

Mar 26, 2026, 9:00 AM EDT - 3 months ago

Abbott hosts conference call for first-quarter earnings

John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening

Mar 24, 2026, 8:00 AM EDT - 4 months ago

John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening

Abbott completes acquisition of Exact Sciences

Mar 23, 2026, 8:50 AM EDT - 4 months ago

Abbott completes acquisition of Exact Sciences

Abbott acquisition of Exact Sciences set to close on March 23, 2026

Mar 20, 2026, 9:00 AM EDT - 4 months ago

Abbott acquisition of Exact Sciences set to close on March 23, 2026

Pivot Bio CEO Chris Abbott to Present at World Agri-Tech Innovation Summit

Mar 13, 2026, 2:17 PM EDT - 4 months ago

Pivot Bio CEO Chris Abbott to Present at World Agri-Tech Innovation Summit

Abbott Laboratories Proxy statement: Proxy Filing

Mar 13, 2026, 8:00 AM EDT - 4 months ago

Abbott Laboratories Proxy statement: Proxy Filing

Abbott Laboratories Proxy statement: Proxy Filing

Mar 13, 2026, 8:00 AM EDT - 4 months ago

Abbott Laboratories Proxy statement: Proxy Filing

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

Mar 12, 2026, 8:00 AM EDT - 4 months ago

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

Exact Sciences Stockholders Approve Acquisition by Abbott

Feb 20, 2026, 4:05 PM EST - 5 months ago

Exact Sciences Stockholders Approve Acquisition by Abbott

EXAS

Abbott declares 409th consecutive quarterly dividend

Feb 20, 2026, 11:38 AM EST - 5 months ago

Abbott declares 409th consecutive quarterly dividend

Carl Abbott's “House of Columns” Brings Sarasota School Modernism to the Market on Longboat Key

Feb 17, 2026, 11:32 AM EST - 5 months ago

Carl Abbott's “House of Columns” Brings Sarasota School Modernism to the Market on Longboat Key

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 5 months ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ADBE AMGN AVGO BAC BMY COF

Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation

Feb 6, 2026, 8:00 AM EST - 5 months ago

Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation

Abbott recalls glucose sensors after seven deaths linked to faulty readings

Feb 4, 2026, 10:49 AM EST - 5 months ago

Abbott recalls glucose sensors after seven deaths linked to faulty readings

Is The Fall In Abbott Stock Justified?

Jan 23, 2026, 9:35 AM EST - 6 months ago

Is The Fall In Abbott Stock Justified?

Abbott faces India scrutiny in cough syrup abuse investigation, documents show

Jan 23, 2026, 6:43 AM EST - 6 months ago

Abbott faces India scrutiny in cough syrup abuse investigation, documents show

Abbott Laboratories Raised Prices, Prompting Sales Slump

Jan 22, 2026, 2:31 PM EST - 6 months ago

Abbott Laboratories Raised Prices, Prompting Sales Slump

MRNA Rallies on Cancer Vaccine Trial, PG Mixed Earnings, ABT Sell-Off

Jan 22, 2026, 11:00 AM EST - 6 months ago

MRNA Rallies on Cancer Vaccine Trial, PG Mixed Earnings, ABT Sell-Off

MRNA PG

Cramer's Mad Dash: Abbott Labs

Jan 22, 2026, 9:53 AM EST - 6 months ago

Cramer's Mad Dash: Abbott Labs

Abbott Laboratories Earnings Call Transcript: Q4 2025

Jan 22, 2026, 9:00 AM EST - 6 months ago

Abbott Laboratories Earnings Call Transcript: Q4 2025

Abbott Laboratories Annual report: Q4 2025

Jan 22, 2026, 9:00 AM EST - 6 months ago

Abbott Laboratories Annual report: Q4 2025

Abbott Laboratories Earnings release: Q4 2025

Jan 22, 2026, 9:00 AM EST - 6 months ago

Abbott Laboratories Earnings release: Q4 2025

Abbott Laboratories Slides: Q4 2025

Jan 22, 2026, 9:00 AM EST - 6 months ago

Abbott Laboratories Slides: Q4 2025

Abbott Stock Slumps on Earnings. What's Weighing on the Medical Devices Maker.

Jan 22, 2026, 7:49 AM EST - 6 months ago

Abbott Stock Slumps on Earnings. What's Weighing on the Medical Devices Maker.

Abbott misses quarterly revenue estimates on weakness in diagnostics segment

Jan 22, 2026, 7:34 AM EST - 6 months ago

Abbott misses quarterly revenue estimates on weakness in diagnostics segment

Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook

Jan 22, 2026, 7:30 AM EST - 6 months ago

Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook

Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms

Jan 20, 2026, 9:00 AM EST - 6 months ago

Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms

therofl
therofl Jul. 15 at 11:24 PM
$ABT suck mike hawk
0 · Reply
therofl
therofl Jul. 15 at 11:12 PM
$ABT shitty shit shit
0 · Reply
yourfinancialteacher
yourfinancialteacher Jul. 15 at 11:10 PM
$ABT 👀
0 · Reply
spearnreel
spearnreel Jul. 15 at 8:20 PM
$BSX Someone liking $ABT earnings due out tomorrow.
1 · Reply
DBRGLong
DBRGLong Jul. 15 at 8:06 PM
$ABT strong buying volume & spike right before the close for us. Someone wanted in prior to earnings tomorrow morning 🥂
0 · Reply
knowinvest
knowinvest Jul. 15 at 6:39 PM
$ABT I think earning will be ok, but the legal issue linked the nutrition business needs to be addressed by the management in order for the SP to move higher
0 · Reply
Oldpuck
Oldpuck Jul. 15 at 5:55 PM
$ABT Very weak heading into earnings
0 · Reply
1212JM
1212JM Jul. 15 at 5:41 PM
$ABT software all collapsing along side healthcare and people dumping money into hardware… they are literally chasing the next bubble. Such great time to buy some great companies at good valuations and prices while avoiding overbought bubbly stuff in $SPY
0 · Reply
DragonOfBosnia
DragonOfBosnia Jul. 15 at 4:47 PM
$ABT $BSX $MDT 25-45% up from here.. by end of year
0 · Reply
eWhispers
eWhispers Jul. 15 at 2:38 PM
#earnings after the close on Wednesday, July 15, 2026, and before the open on Thursday, July 16, 2026 https://www.earningswhispers.com/calendar $TSM $UNH $UAL $GE $ABT
0 · Reply
spearnreel
spearnreel Jul. 15 at 2:10 PM
$BSX You’ll never beat “them” but have full right to always join “them”. Yesterday’s hit piece capitulation games across the entire med tech sector should serve as buy indicator imo. $43’s today to solidify how these games are played. Blueprint for trading moving forward. $JNJ $ISRG $ABT
0 · Reply
Timroach
Timroach Jul. 15 at 1:28 PM
$ABT way under valued
0 · Reply
FundaTech
FundaTech Jul. 15 at 3:17 AM
$ABT Likely going to 105 after earnings release.
2 · Reply
DragonOfBosnia
DragonOfBosnia Jul. 14 at 11:06 PM
$BSX $MDT $ABT gapped down, these medical device companies taking a whooping all have forward PE under 15
0 · Reply
1212JM
1212JM Jul. 14 at 10:53 PM
$ABT for me this and other blue chips trading like this just validates the market is in a bubble. Totally irrational people chasing ai and tech and dumping everything not tied to a data center. Question is - how long does it last?
0 · Reply
nio11
nio11 Jul. 14 at 9:04 PM
$ABT ER this Thursday makes me wonder if this will get sold off hard down to the 70s
2 · Reply
mreitnour
mreitnour Jul. 14 at 8:26 PM
$ABT Apparently, 54 consecutive years of increased dividend payouts and a ”meager” annual EPS growth rate of around 10% is rationale for a 30% decline in share price. Wall Street logic. Brilliant.
0 · Reply
Enjoy_Life_Bro
Enjoy_Life_Bro Jul. 14 at 7:58 PM
$ABT No one is expecting earnings to be positive after the recent overpriced acquisition. It is going to take years to recover. $EXAS took them to the cleaners on that acquisition and most investors will not be forgiving
0 · Reply
william2012
william2012 Jul. 14 at 7:51 PM
$ABT This always drops hard earning report.
1 · Reply
1212JM
1212JM Jul. 14 at 6:40 PM
$ABT absolutely ridiculous.
0 · Reply
Chickenstick1
Chickenstick1 Jul. 14 at 6:12 PM
$QDEL Depending on what they can get for their in office test business, I think this can trade above $30. I bet $ABT makes a bid because they have the cash and manufacturing footprint to make it an extremely profitable segment. But, as for $QDEL the divestiture will immediately make them FCF positive.
0 · Reply
mreitnour
mreitnour Jul. 14 at 3:27 PM
$ABT How does the sentiment on this stock change so dramatically over the course of one week with no news provided? Wall Street shenanigans at its finest.
0 · Reply